Regulating Urine pH Levels to Alleviate Chronic Joint Pain
NCT01421160 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-05-16
Summary
This study aims to determine the causal relationship between regulating urine pH levels between 7.0 and 7.5 and decreasing chronic joint pain. The investigators hypothesize that maintenance of an alkaline urinary pH will result in a decrease in personally reported levels of chronic joint pain using a citrate treatment regimen.
Conditions
Interventions
- DRUG
-
sodium citrate and citric acid
sodium citrate and citric acid equivalent to 1 mEq/ml bicarbonate (usual dose 10-30 mls/day diluted with water)
Sponsors & Collaborators
-
Texas Tech University Health Sciences Center, El Paso
lead OTHER
Principal Investigators
-
Dennis W Miller, MD · Department of Anesthesiology; Texas Tech University Health Sciences Center; Paul L. Foster School of Medicine
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure
NCT00662610 ·Status: COMPLETED ·Phase: PHASE1
-
PF-06372865 In Subjects With Chronic Low Back Pain
NCT02262754 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans
NCT01280006 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
NCT00662896 ·Status: COMPLETED ·Phase: PHASE1
-
Variability in Response to Non-steroidal Anti-inflammatory Drugs
NCT02502006 ·Status: TERMINATED ·Phase: PHASE1
-
Celecoxib (Celebrex) in the Management of Acute Renal Colic
NCT00304317 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
NCT00674856 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects
NCT03396250 ·Status: COMPLETED ·Phase: PHASE1
-
Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®
NCT00532012 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Theramine on Chronic Back Pain
NCT01468025 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging
NCT05307627 ·Status: WITHDRAWN
-
A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects
NCT02108548 ·Status: TERMINATED ·Phase: PHASE1
-
RN624 In Adult Patients With Chronic Low Back Pain
NCT00584870 ·Status: COMPLETED ·Phase: PHASE2
-
Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome
NCT02063698 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-inflammatory Agents and Cholesterol Metabolism
NCT01279395 ·Status: TERMINATED
-
Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
NCT00137033 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of SP-104
NCT05002946 ·Status: COMPLETED ·Phase: PHASE1
-
Actual Use Trial of Naproxen Sodium
NCT01427803 ·Status: COMPLETED ·Phase: PHASE3
-
Self Selection Trial of Naproxen Sodium
NCT01383486 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
NCT00749385 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
NCT00807846 ·Status: COMPLETED ·Phase: PHASE4
-
NSAID Drug Interaction Study
NCT01884272 ·Status: COMPLETED ·Phase: PHASE1
-
Naproxen for Pain Control With Intrauterine Device Insertion
NCT02388191 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole
NCT03092193 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Trial of Naproxen Sodium/ Diphenhydramine
NCT01365052 ·Status: COMPLETED ·Phase: PHASE3